KZR
Kezar Life Sciences Inc
NASDAQ: KZR · HEALTHCARE · BIOTECHNOLOGY
$7.31
+0.14% today
Updated 2026-04-30
Market cap
$53.59M
P/E ratio
—
P/S ratio
6.03x
EPS (TTM)
$-7.66
Dividend yield
—
52W range
$4 – $8
Volume
0.1M
Kezar Life Sciences Inc (KZR) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-9.76M | $-8.11M | $-20.79M | $-29.88M | $-36.95M | $-42.44M | $-58.85M | $-81.64M | $-74.21M | $-51.78M |
| Capital expenditures | $132000.00 | $389000.00 | $1.12M | $607000.00 | $194000.00 | $316000.00 | $1.58M | $1.81M | $29000.00 | $8000.00 |
| Depreciation | $154000.00 | $175000.00 | $690000.00 | $1.30M | $1.54M | $1.51M | $1.02M | $1.07M | $1.04M | — |
| Stock-based comp | $128000.00 | $203000.00 | $1.99M | $4.01M | $4.94M | $7.60M | $14.01M | $18.14M | $13.01M | $8.96M |
| Free cash flow | $-9.89M | $-8.50M | $-21.91M | $-30.48M | $-37.14M | $-42.75M | $-60.42M | $-83.45M | $-74.24M | $-51.78M |
| Investing cash flow | $-132000.00 | $-389000.00 | $-83.90M | $20.42M | $-56.50M | $-28.44M | $-91.39M | $76.05M | $80.43M | — |
| Financing cash flow | $36000.00 | $49.76M | $77.91M | $272000.00 | $99.64M | $112.58M | $127.86M | $638000.00 | $103000.00 | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $-26.78M | $-9.19M | $6.20M | $41.70M | $-22.38M | — | — | — |